Beacon Securities analyst Gabriel Leung raised his price target on VitalHub (VitalHub Stock Quote, Chart, News, Analysts, Financials TSXV:VHI) to C$14.50 from C$14.00 on June 19, following the company’s completion of its acquisition of UK-based Induction Healthcare Group. While the deal is expected to temporarily weigh on margins during integration, Leung said he remains confident […]
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.60 price target on Sernova Biotherapeutics (Sernova Biotherapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:SVA) in a June 16 report, citing strong early clinical results and a promising pipeline, but warning the company will need to secure more funding in the near term. Sernova […]
Share
Tweet
Share
